ARCHIVES

Funding Opportunities.

This article is from The Cancer Letter archive.

Vol. 28 No. 12 | March 22, 2002

Download PDF Visit The Full Archive

Related Articles

NCAB Sets Bypass Budget Figures at $1.074 Billion

May 28, 1982

New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial

September 24, 2010

FDA Approves Erbitux for Head & Neck Cancer.

March 3, 2006

Bahama Government Closes Clinic “Immediately And Permanently” After AIDs Contamination Report

July 26, 1985

Nexavar Improves PFS In Phase III Trial

January 25, 2013

New Drug Reverses Damage To Liver In Stem Cell Transplant

September 27, 2002